- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Alemtuzumab in autoimmune cytopenias
Total 457856 results
-
Hospital Universitario Dr. Jose E. GonzalezCompletedIdiopathic Thrombocytopenic Purpura | Anemia, Hemolytic, AutoimmuneMexico
-
Phramongkutklao College of Medicine and HospitalBayerTerminated
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...RecruitingMyelodysplastic Syndromes | Immune Thrombocytopenia | Autoimmune Hemolytic Anemia | Cold Agglutinin Disease | Autoimmune Neutropenia | Chronic Idiopathic NeutropeniaItaly
-
Alpine Immune Sciences, Inc.RecruitingImmune Thrombocytopenia | Idiopathic Thrombocytopenic Purpura | Cold Agglutinin Disease | Warm Autoimmune Hemolytic AnemiaUnited States, Canada, Australia, Turkey, United Kingdom
-
BiogenRecruitingMultiple SclerosisUnited States
-
Sheba Medical CenterSanofiRecruiting
-
National Cancer Institute (NCI)RecruitingImmune System Diseases | Lymphoproliferative Disorders | Common Variable Immunodeficiency | Primary T-cell Immunodeficiency Disorders | Autoimmune LymphoproliferativeUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Brigham and Women's HospitalGenzyme, a Sanofi CompanyNot yet recruitingMultiple SclerosisUnited States
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Multiple Sclerosis SocietyRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Haukeland University HospitalRecruitingMultiple SclerosisNorway, Sweden, Denmark, Netherlands
-
Paul SzabolcsRecruitingCongenital Bone Marrow Failure Syndromes | Inflammatory Conditions | Primary Immunodeficiency (PID) | Inherited Metabolic Disorders (IMD) | Hereditary Anemias | Systemic Juvenile Idiopathic Arthritis (sJIA)United States
-
Washington University School of MedicineRecruitingSevere Combined Immunodeficiency | Chronic Granulomatous Disease | DiGeorge Syndrome | Hemophagocytic Lymphohistiocytosis | Wiskott-Aldrich Syndrome | X-linked Lymphoproliferative Syndrome | X-linked Agammaglobulinemia | Chediak-Higashi Syndrome | IPEX | Autoimmune Lymphoproliferative Syndrome | Common Variable... and other conditionsUnited States
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
Meyer Children's Hospital IRCCSActive, not recruitingCytopeniaItaly, United States, Belgium
-
Queen Mary University of LondonActive, not recruiting
-
Maritime NeurologyCompletedFrequency of Infusion Reactions in Novel Versus Standard Protocol in Multiple SclerosisCanada
-
Genzyme, a Sanofi CompanyActive, not recruitingMultiple SclerosisPortugal, Turkey, Italy, Austria, Belgium, France, Netherlands, Poland, Russian Federation, United Kingdom
-
University of AarhusGenzyme, a Sanofi CompanyCompletedMultiple SclerosisDenmark
-
University of AlbertaAlberta Innovates Health SolutionsActive, not recruitingDiabetes Mellitus, Type 1Canada
-
IMPULS Endowment FundCompleted
-
Karolinska InstitutetPatient-Centered Outcomes Research Institute; Kaiser Foundation Research InstituteActive, not recruitingRelapsing-remitting Multiple SclerosisSweden
-
Genzyme, a Sanofi CompanyTerminatedMultiple SclerosisUnited States, Australia, Austria, Belgium, Canada, Denmark, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
Universitätsklinikum Hamburg-EppendorfNeovii Biotech; Clinical Trial Center North (CTC North GmbH & Co. KG)TerminatedRelapsing-Remitting Multiple SclerosisGermany
-
Queen Mary University of LondonTerminated
-
University of Texas Southwestern Medical CenterGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis (MS)United States
-
University Hospital MuensterGenzyme, a Sanofi CompanyCompletedMultiple Sclerosis, Relapsing-RemittingGermany
-
Clinique Neuro-OutaouaisCogState Ltd.CompletedMultiple SclerosisCanada
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisSpain
-
University of Southern CaliforniaTerminatedMultiple SclerosisUnited States
-
Children's Hospital of PhiladelphiaCompletedRheumatoid Arthritis | Lupus Erythematosus, Systemic | Idiopathic Thrombocytopenic Purpura | Inflammatory Bowel Disease | Anemia, Hemolytic, Autoimmune | Evans Syndrome | Autoimmune Pancytopenia | Autoimmune Lymphoproliferative Syndrome (ALPS) | Autoimmune NeutropeniaUnited States
-
University Hospital MuensterUnknown
-
Cambridge University Hospitals NHS Foundation TrustTerminatedMultiple SclerosisUnited Kingdom
-
University of ChicagoGenzyme, a Sanofi CompanyCompleted
-
University of British ColumbiaGenzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisCanada
-
Northwestern UniversityTerminated
-
Institut Paoli-CalmettesCHU de ReimsUnknownAutoimmune Cytopenia Associated With Chronic Lymphocytic LeukemiaFrance
-
Glostrup University Hospital, CopenhagenGenzyme, a Sanofi CompanyUnknown
-
Johns Hopkins UniversityGenzyme, a Sanofi CompanyWithdrawnChronic Inflammatory Demyelinating NeuropathyUnited States
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands, Spain, Germany, Israel, United Kingdom, Canada, Australia, United States, Italy, Argentina, Croatia, Russian Federation, Poland, Czechia, Belgium, France, Brazil, Austria, Denmark, Mexico, Serbia, Sweden, Ukraine
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, Denmark, Canada, United States, Netherlands, Argentina, Austria, Belgium, Brazil, Croatia, Czech Republic, France, Germany, Israel, Italy, Mexico, Poland, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom
-
Duke UniversityTerminatedSystemic Lupus Erythematosus | Systemic SclerosisUnited States
-
Genzyme, a Sanofi CompanyCompletedRelapsing-remitting Multiple SclerosisBelgium, Spain, France, Netherlands
-
University of Wisconsin, MadisonWithdrawnNew Onset Type 1 Diabetes MellitusUnited States
-
Hadassah Medical OrganizationUnknown
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Russian Federation, Poland, Croatia, United Kingdom
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
New York Medical CollegeTerminatedSystemic Lupus Erythematosus | Systemic SclerosisUnited States
-
Samuel Forrester Hunter, MD, PhDUnknownMultiple SclerosisUnited States